Fred Alger Management’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.6K Sell
14,033
-9,124
-39% -$30K ﹤0.01% 424
2026
Q1
$62.3K Sell
23,157
-4,864
-17% -$13.5K ﹤0.01% 444
2025
Q4
$61.4K Sell
28,021
-31,792
-53% -$78.8K ﹤0.01% 458
2025
Q3
$140K Hold
59,813
﹤0.01% 445
2025
Q2
$90.9K Sell
59,813
-417,397
-87% -$651K ﹤0.01% 431
2025
Q1
$661K Sell
477,210
-1,839,014
-79% -$3.92M ﹤0.01% 346
2024
Q4
$5.26M Sell
2,316,224
-1,803,170
-44% -$6.33M 0.03% 237
2024
Q3
$19.4M Buy
4,119,394
+1,596,512
+63% +$9.24M 0.09% 136
2024
Q2
$18.9M Sell
2,522,882
-587,432
-19% -$7.2M 0.09% 136
2024
Q1
$53.1M Sell
3,110,314
-216,818
-7% -$4.65M 0.26% 79
2023
Q4
$75.5M Sell
3,327,132
-932,323
-22% -$15.7M 0.41% 65
2023
Q3
$64.8M Sell
4,259,455
-313,431
-7% -$4.28M 0.37% 71
2023
Q2
$59M Buy
4,572,886
+557,576
+14% +$6.05M 0.3% 94
2023
Q1
$33.2M Buy
4,015,310
+3,279,361
+446% +$30.7M 0.18% 132
2022
Q4
$6.81M Buy
+735,949
New +$2.68M 0.04% 239
2021
Q4
Sell
-214,721
Closed -$2.61M 518
2021
Q3
$2.61M Buy
+214,721
New +$1.98M 0.01% 332

Other funds holding CABA

Fred Alger Management's CABA Position: Q2 2026 in Review

Fred Alger Management reduced its Cabaletta Bio (CABA) stake by 39% in Q2 2026, selling an estimated $30K and leaving 14,033 shares worth $43.6K. The position accounts for ﹤0.01% of the portfolio, ranked #424.

Fred Alger Management first reported a position in CABA in Q3 2021 and has held it in 16 quarters since. The position peaked at $75.5M in Q4 2023. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Fred Alger Management held 14,033 shares of Cabaletta Bio worth $43.6K as of Q2 2026.
  • Fred Alger Management sold 9,124 Cabaletta Bio shares in Q2 2026, an estimated $30K.
  • Cabaletta Bio made up ﹤0.01% of Fred Alger Management's portfolio in Q2 2026, its #424 holding.
  • Fred Alger Management first reported a position in Cabaletta Bio in Q3 2021 and has held it in 16 quarters since.
  • Fred Alger Management's Cabaletta Bio position peaked at $75.5M in Q4 2023.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.